Background: Portugal has a strong tradition of conventional western healthcare. So it provides a natural case study for the relationship between Complementary/Alternative Medicine (CAM) and Western Medicine (WM). This work aims to test the relationship between CAM and WM users in the diagnosis and treatment stages and to estimate the determinants of CAM choice. Methods: The forth Portuguese National Health Survey is employed to estimate two single probit models and obtain the correlation between the consumption of CAM and WM medicines in the diagnosis and treatment stages. Results: Firstly, both in the diagnosis and the treatment stage, CAM and WM are seen to be complementary choices for individuals. Secondly, self-medication also shows complementarity with the choice of CAM treatment. Thirdly, education has a non-linear relationship with the choice of CAM. Finally, working status, age, smoking and chronic disease are determinant factors in the decision to use CAM.
Implications for policy makers
and beliefs (6, 7) . These reasons have been also identified for Portuguese users of CAM (8) .
The efficacy and safety of the use of CAM therapies are controversial. On the one hand, the benefits arising from the use of particular CAM therapies are recognized for some diseases such as cancer, asthma, diabetes, cardiovascular diseases, liver diseases and rheumatology (9) (10) (11) (12) . On the other hand, these benefits lack thorough scientific and clinical evidence (13) (14) (15) . Moreover, undesirable interactions between CAM and WM treatments are well-known. For instance, the pharmacokinetic interactions between St. John's wort and certain prescribed drugs (16) or between cat's claw and specific blood medication (17) are well-documented. Several research papers review the interaction between herbs, homeopathic and allopathic drugs (18) (19) (20) (21) . The interactions between traditional Chinese medicines and western therapeutics have been reviewed recently (22) . While acknowledging both the reasons why people choose CAM and also the concern for patient safety and treatment efficacy, the following questions can be raised:
• Are CAM and WM substitutes or complements in the individual decision regarding healthcare? • How is the relationship between CAM and WM different in the diagnosis and treatment stages? • What are the main factors determining the individual choice of CAM? Portugal has a strong tradition of conventional healthcare and so the National Health System does not include any CAM provision. The Portuguese public health system covers the whole population where care is mainly provided without significant copayments, except in the case of drugs [Further details of the Portuguese health system can be found in Barros and Simoes (23) ]. Despite this wide coverage, some people choose to buy voluntary private health insurance; it is estimated that around 20% of the population is covered by private voluntary health insurance (24) 1 . The total cost of any CAM provision is borne by the individual. Moreover, because of the strong tradition of conventional healthcare, physicians know little about CAM and they do not approve it (25, 26) . This attitude helps to explain the ignorance people have of CAM and the fact that they do not actively request it. This backdrop means that Portugal provides a natural case study for the relationship between CAM and WM medicines. This work employs the forth Portuguese National Health Survey, published in 2006. The questions in this survey allow a distinction to be made both between the use of CAM and WM, and also between the diagnosis and the treatment, once some illness symptoms arise. Two probit models are estimated, reflecting the binary nature of the target and dependent variables showing whether or not CAM was used, while also allowing analysis of the explanatory variables underlying the behaviour of the dependent variables. The probit estimates provide the correlation between the use of CAM and WM. The theoretical basis for this analysis is the well-known model of demand for health proposed by Grossman (27) . Accordingly, factors such as age, income and education are viewed as determinants of the demand for health. The applications of this work are several and they provide the empirical background for the independent variables used in the work presented here (28) (29) (30) (31) . A relevant branch of the existing literature is related to the efficacy, safety, and also cost effectiveness of CAM (32, 33) . There is also some work on the use of CAM for particular diseases and on the attitude of physicians towards CAM (34, 35) . A systematic review of the literature for a selection of countries is carried out by Harris and Rees (5) . For the case of developing countries, Das and Choudhury (36) determine the socio-economic factors of CAM use and estimate the cost effectiveness of such choice in India. However, they do not study the correlation between the uses of CAM and WM. Van Gameren (37) analyzes the effect of insurance coverage on the use of CAM in Mexico. He finds that CAM is substituted by WM covered by insurance and that higher income households substitute less than lower income households. The USA is the most studied of all the developed countries. Here, the work of Wolsko et al. (38) is worthy of note, where a study is made of the effect insurance coverage has on the frequency of CAM use, finding a positive correlation. Pagan and Pauly (6) (40) . Finally, an older study by Astin (7) looks for the different motives that led people to choose CAM in the USA, but no correlation is made with traditional medicine. The literature on Europe has been increasing in last few years and concern with CAM in the health systems is flourishing. It is possible to find research work studying nearly every European country while a vast survey was undertaken by the CAMbrella project in 2009-12 (41, 42) . This project represented a step towards harmonizing existing knowledge and determining the knowledge gaps in this field. The results of the project yielded recommendations for the European Commission and the European Parliament. European studies of the prevalence of CAM tend to be poor and heterogeneous (43) and also tend to display huge variability in the national regulatory management which makes a comparison across the EU nearly impossible (44) . Some of the research published looks at the determinants of the use of CAM in countries like Finland (45) , Italy (46, 47) , Germany (48) , Sweden (49, 50) and the UK (51) . An overview of the results presented by this European research shows that there is a tendency to find common factors explaining the use of CAM; users are more likely to be women, middle aged, well-educated and from higher income brackets and suffering chronic conditions. Nevertheless, no work was found studying the relationship between CAM and WM in general, despite work having been done looking at the relationship for specific conditions such as cancer (52, 53) and HIV (54) . Our work tries to fill a gap in the research regarding the use of CAM in Southern European countries. Up until now, little work has been done: i) testing the relationship between CAM and WM, where the WM is mainly provided by a National Health System that does not include any CAM, and ii) estimating the determinants of CAM choice. iii) Moreover, as far as the author is aware, no research has been done differentiating CAM from WM in the diagnosis and treatment stages. The main result of this analysis is that for both cases of diagnosis and treatment CAM and WM are complementary choices for the individual. This result and the other results presented in this work provide a new and broader view concerning the use of CAM in Portugal. As a start point, health policy-makers should take into account the well-being and satisfaction of patients. Not only is this relevant from a safety and efficacy perspective, but also from a standpoint of freedom of choice by individuals. From a market perspective, private health insurance providers may see CAM as a niche to be explored.
Methods

Data and descriptive statistics
The data employed is taken from the forth Portuguese National Health Survey (2005/06) providing a representative sample for the country as a whole, since it results from a multi-stage random probability selection design. The survey includes a broad set of questions covering several topics from personal identification to sport and drinking habits. The responses received came from all people in the selected households who accepted to participate. Nationally, 76% of the selected households agreed to participate; reasons given for non-participation included "nobody resident at that address", "incompatible schedules with interviewers" and "refusal" (the rate of refusal was only 5%). Trained interviewers asked the questions and recorded the answers during face-to-face interviews with a household representative or the individual himself. The working sample covers all 33,770 adults (older than 18), where 47.5% are males and 52.5% are females. There are two survey questions that relate to the use of CAM. One question asks about the diagnosis and the other about the treatment after a pre-reported illness or symptoms, as shown in Figure  1 . In answering the questions, respondents are obliged to choose one of three answers: "yes", "no" or "do not know". The number of "do not know" answers is insignificant. The relevant questions are presented in the Appendix 1.
A total of 855 people report using CAM, either in one or both the diagnosis and treatment stages. Table 1 shows the number of users of WM and CAM, according to their choices in the diagnosis and/or treatment stages. It should be noted that it is not possible to sum the numbers presented in Table 1 because there are some people who use CAM purely for diagnosis, other people who use CAM purely for treatment and other people again who use CAM for both diagnosis and treatment. In order to refine the descriptive statistics on the use of CAM and because information on the use of CAM is preceded by information recording a feeling of being ill in the two weeks prior to the survey, we now present some additional statistics on the use of CAM. The supporting structure of the described statistics is presented in Figure 2 . The number of adults reporting "feeling ill" in the two weeks prior to the survey was 5,070. Table 2 shows that out of this group of 5,070 people, 2,056 looked for a WM professional to get a diagnosis and 68 looked for a CAM diagnosis, while 379 people used a treatment provided by CAM. The total number of people reporting using CAM and feeling ill is 408. As before, in Table 2 , the sum of the entries does not yield the total users of CAM because people use CAM in one or both stages of healthcare. For those people that sought a WM diagnosis (that is 2,056 people), Table 3 Table 4 show that the choices of CAM and WM for diagnosis and treatment exhibit in all cases a strong or medium positive correlation. Moreover, they are not strongly associated, that is, each pair of two variables are far from being equal to each other since Cramer's V statistic is very low. The survey questions supporting the variables relating to the choice of CAM or WM are presented in Appendix 1, along with information on how the variables were created.
Method and model
The relationship between CAM and WM may be either complement or substitute. These concepts are borrowed from the economic theory, in the sense that when the consumption of CAM and WM increases, then they tend to be complementary, but when the consumption of CAM decreases and the WM increases, then they are substitutes. To find the relationship between CAM and WM, two linear equations are estimated, based on several control variables. This econometric approach to test the complementarity of goods and services in health has been used before (55) (56) (57) (58) . The dependent variables of the econometric model are CAMtreat and CAMdiagn. These are binary variables, taking a value of 1 if the individual reported using CAM and 0 otherwise. The aim to estimate the main determinants of a CAM decision justifies the choice of CAM as a dependent variable. The independent variables are listed and described in Another relevant economic estimate concerns the correlation between income and the choice of CAM. If the estimated coefficient is positive, then CAM is a normal good, however, if it is negative, then it is an inferior good. Finally, the estimated coefficients for the control variables provide information about the correlation each variable has with the choice of CAM, given that all the other variables are constant.
Results
The estimated models are presented in the next table and were obtained with software STATA version 9 ( Table 6 ).
The most relevant result is that CAM and WM are complements, both in the diagnosis and treatment stages, because estimated coefficients are positive and statistical significant. The second important result is that people, having sought a WM diagnosis, may look for a CAM treatment, as shown in estimated coefficients of model 1. This result actually shows how CAM and WM are related for patients who seem to value both healthcare contributions. This corroborates previous medical studies that showed the importance of CAM in particular diseases. The third result worth stressing is that the medical literacy and empowerment of patients, captured by the selfmedication variable, contributes towards choosing CAM. Moreover, this medical literacy and empowerment can also be captured by the existence of chronic disease. These patients tend to understand their condition well, along with what makes them feel better, and they are usually willing to try new approaches to their illness. This is why suffering from at least one chronic disease is a determinant factor in choosing CAM. The other result concerning literacy comes from the significance education holds for the choice of CAM treatment, but not for the CAM diagnosis. The higher the level of education, the more likely it becomes for individuals to choose a CAM treatment. However, the marginal effect on individuals' choice as education increases is negative; education presents an inverted U-shape relationship with CAM treatment.
A somewhat surprising result is that smokers are less likely to look for a CAM diagnosis than a CAM treatment. The descriptive statistics show that 810 smokers use CAM treatments while only 124 smokers use a CAM diagnosis. It is not possible to identify the reasons that encouraged smokers to look for CAM. However, it follows that smoking as a condition does not need a diagnosis, and those wishing to follow programs designed to quit smoking are looking for a CAM treatment and not a diagnosis. Finally, no significant relationship was found between the choice of CAM and income, leaving us unable to reach a conclusion as to whether CAM represents a normal or inferior good for consumers. These results obtained here are relevant for health policy matters. Firstly, it may be important for the well-being of patients to have a national health system that integrates both types of medicines. This could help increase the clarity and availability of information for physicians and for patients, and increase communication between them, so that higher efficacy and safety, as well as, access equity could be achieved. Secondly, it may be inferred that there exists an increasing interest in including CAM in private health insurance. While this practice is already current in other European countries, it is now becoming more common in Portugal due to the positive correlation between CAM and WM medicines. Thirdly, the characterization of those who choose CAM is helpful for policy design. People suffering from chronic diseases, smokers, working and mature adults are those who are more likely to appreciate such health policies. Finally, it could be argued that the estimation of these two probit models could be done simultaneously, in order to account for possible endogeneity. A bivariate probit was estimated where upon the results were found to be identical to the original estimation. Moreover, no significant correlation was found between the residuals of both probits regressions, which most likely means there is no endogeneity. This can be explained by the strong belief and cultural bias towards conventional medicine in Portugal.
Conclusions and Discussion
The increasing use of CAM by the Portuguese follows the European trend. Patients need for freedom of choice and, for the sake of safety and efficacy of treatment, WM and CAM healthcare should be provided in a joint and integrated health system. From a different perspective, private health insurance providers may exploit the desire of people for access to both WM and CAM and explore a niche of this market. In particular, advertising such health insurance to mature working adults who tend to smoke more often. The main disadvantage of this analysis is the number of people self-reporting using CAM. This number may be smaller than the true number of people using CAM diagnosis and treatment. This under-reporting can be explained by the fact that Portuguese society is WM dominated and CAM is little known or understood, leading people to not openly discuss its use. Hence, one potential limitation arises from the fact that it is not possible to interpret what is the meaning of negative answers to the survey questions used to create the observable variables on use of CAM. Does it mean "no use of CAM"? Or does it mean "I do not want to talk about it"? Lastly, the economic quantitative analysis and the database used in this work does not allow for a qualitative analysis where cultural, social and anthropological features also play a role. The emphasis of the work presented here has quantitative nature.
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Endnotes
This work was done before the full effects of the debt crisis took hold in 2011.
At that time, the National Health Service (NHS) copayments were fairly low. In 2010, it was estimated that on average about 30% of total expenditure on healthcare was private, mainly in the form of out-of-pocket (OOP) payments. After 2011, some reforms have been implemented in order to decrease public expenditure on health (25) . However, an assessment of these measures has not been made. Moreover, due to financial constraints, there is no statistical information about the current use of CAM nor is there any health survey. I) Question for Diagnosis Stage "Related to that (health) problem you mentioned before, to whom did you go?" 1) Doctor 2) Nurse 3) Pharmacist 4) Acupuncturist 5) Homeopaths 6) Osteopaths 7) Naturopaths 8) Phytotheraphist 9) Chiropractor 10) Herbal expert 11) Healer 12) Other health professional Variable CAMdiagn is created by at least one answer being chosen from options 4 to 10. Variable WMdiagn is created by at least one answer being chosen from options1 to 3.
II) Question for Treatment Stage
"In relation to the (health) problem you mentioned before, what treatment have you administered in the last two weeks?" 1) Herbs and teas 2) Change of food 3) Took drugs you knew 4) Took drugs advised by friends 5) Took drugs advised by doctor 6) Acupuncture 7) Homeopathy 8) Osteopathy 9) Naturapathy 10) Phytotherapy 11) Chiropractic 12) Something else Variable CAMtreat is created by at least one answer being chosen out of theoptions1 and 6 to 11. Variable WMtreat is created by at least one answer being chosen from options 3 to 5.
